From: jsuttor@netcom.com (Jeff Suttor)
Subject: MAPS v3, n4 & events & publications/tapes & membership info
Organization: Netcom - Online Communication Services  (408 241-9760 guest) 
Date: Sat, 19 Dec 1992 01:46:31 GMT

The following documents were scanned with permission.  An attempt was 
made to correct scanning errors but please refer to the original source 
if any questions.

Enclosed are ...  Table of contents for MAPS v3, n4, Winter, 1992.  
Proposed upcoming MAP events.  A list of publications, audiotapes & 
videotapes available from MAPS.  Membership information.  I have no 
affiliation with MAPS other than a great respect of what they are doing.

--------------------------  Table of Contents  ------------------------

Multidisciplinary Association for Psychedelic Studies, Inc.
Winter 1992  Vol.lll  No.4

FDA-Approved MDMA Protocol                                       2
Follow-up to Leary's Concord Prison Recidivism Study             4
Medical Marijuana                                                6
DMT and Psilocybin                                               8
One Foot in the Future Book Review                              10
"Worlds of Consciousness" Conference Report                     14
MAPS and the "Worlds of Consciousness" Conference               16
PET Scan Study of Ketamine and Psilocybin                       18
Political and Psychological Dynamics of Swiss Psychedelic
     Psychotherapy                                              21
Ketamine Psychedelic Therapy for Alcoholism and Neurosis in
     Russia                                                     24
Ayahuasca Use in Brazil                                         29
MDMA's Patentability and Orphan Drug Potential                  32
MAPS Membership and Videos and Publications                     34
SF Examiner Article                                             36

"CHANGE", the mantra of President-elect Clinton, is revitalizing the 
field of psychedelic research.  The first flickerings of renewed 
research began a few years ago in Switzerland (seepage 21), in Russia 
(see page 24), and in the US.  These pioneering projects,approved after 
years of struggle with regulatory authorities, successfully demonstrated 
that scientific progress could be made without exacerbating drug abuse 
or catalyzing cultural turmoil.  To the contrary, intriguing hints were 
found suggesting that the appropriate use of psychedelics could help in 
the treatment of substance abuse and could heal some of the cultural 
wounds associated with the War on Drugs.  

In July, FDA's Drug Abuse Advisory Committee recommended the resumption 
of psychedelic research, subject to the condition that the standards of 
methodology and proof that the FDA uses to critique claims about other 
drugs must also be applied to psychedelics.  Over the summer, the 
Massachusetts Department of Corrections approved access to its files so 
that a follow-up study could be conducted to Dr.  Leary's 1962 inquiry 
into the use of psilocybin to reduce recidivism in prisoners (see page 
4).  In October, the FDA approved the first human study of MDMA (see 
page 2-3 and 36).  The FDA may soon approve marijuana research in the 
treatment of HIV-related wasting syndrome (see page6) and ibogaine to 
treat substance abuse.  Also, NIDA will probably fund DMT and psilocybin 
research (see page 8).  

Researchers in Switzerland are using PET scans to study ketamine and 
psilocybin (see page 18).  In Brazil, the religious use of the plant 
mixture, ayahuasca, has been accepted as legal (see page 29).  
Dennis McKenna's proposal for a biomedical investigation of ayahuasca, 
reported in the last MAPS newsletter, has been funded and will begin 
shortly.  In Russia,approval is likely for a study of MDMA's potential 
to treat alcoholics.  In Germany, psychiatrists will soon publish data 
about MDE research and may obtain approval to research MDMA.  

For MAPS, the renewal of psychedelic research carries its own imperative 
for change.  Facilitating communication between researchers and 
regulators is more essential, delicate, time-consuming, and expensive 
than ever before.  This newsletter is our lengthiest ever printed and is 
being sent to a record 375 MAPS members and 300 interested others.  MAPS 
has demonstrated success by gaining approval for MDMA research after a 
seven-year struggle.  Though I continue to donate my time, responding to 
the challenge of MAPS' new opportunities requires my full time attention 
and has encouraged me to take a leave of absence from a Ph.D.  program 
in Public Policy at Harvard's Kennedy School of Government.  To be viable 
in the long run, MAPS needs additional funds both to pay for research 
and to support a full-time president.  Future progress depends upon the 
extent to which we conduct scientifically proficient and culturally 
sensitive research, and upon your generosity in donating funds to 
support MAPS' work.  

Rick Doblin, MAPS President
MAPS
1801 Tippah Avenue
Charlotte, NC  28205
phone (704) 358-9830
FAX   (704) 358-1650

-------------------  Proposed Upcoming MAP Events  --------------------

TO:     MAPS Members and Interested Parties
FROM:   Rick Doblin, MAPS President
DATE:   December 7, 1992
RE:     Upcoming Events

There are several possible events in the early stages of planning that 
I'd like to mention briefly to you.  These events may commemorate the 
50th anniversary of Albert Hofmann's discovery of LSD and proceeds would 
go partly to benefit MAPS and psychedelic and medical marijuana research.  

While the details will follow in the next newsletter, we are thinking to 
hold the first event in Santa Cruz or the San Francisco Bay area on 
Friday night, April 16th, 1993.  This date marks 50 years to the day 
that Dr.  Albert Hofmann accidentally ingested a small amount of LSD and 
discovered that it had unusual psychoactive effects.  MAPS, the Island 
Foundation, perhaps the Albert Hofmann Foundation and other groups will 
co-sponsor a celebration and tribute to LSD.  The concept is to create a 
cultural/artistic event that would feature musicians, painters, authors 
and poets expressing through their work what LSD has meant to them.  In 
addition, we hope to have some people not normally associated with the 
psychedelic movement as well as psychedelic pioneers speaking about the 
role LSD has played in their lives.  

The following day, Saturday, April 17, we (in this case MAPS and the 
Cannabis Action Network and their campus-based activists) are thinking 
of organizing a national celebration of Bicycle Day, commemorating the 
bicycle ride that Albert Hofmann took home from the laboratory on April 
19 after intentionally ingesting 250 micrograms of LSD.  Originated and 
trademarked by Dr.  Tom Roberts, one of the founders of the International 
Transpersonal Association, Bicycle Day has been celebrated for about 
four years by an increasing number of people on the nearest Saturday to 
April 19.  We are considering asking people to sponsor volunteers
(mostly college students) to ride their bikes for a certain number of 
miles, donating a certain amount per mile to support research into 
psychedelics and the medical use of marijuana.  

I am also exploring the possibility of asking rave organizers around the 
US and in other countries to arrange simultaneous "Raves for Research" 
on the night of April 17 to raise funds for MAPS for research into LSD, 
MDMA, and marijuana.  Rave organizers have already raised funds for 
Greenpeace, Amnesty International, various Rainforest groups, AIDS 
research, pro-choice groups, as well as other causes.  

In addition, the Albert Hofmann Foundation is in the early planning 
stages of a large scientific conference on LSD to be held in May in Los 
Angeles, which Dr.  Albert Hofmann himself may attend.  

If you would like to help with any of the potential MAPS events, if you 
have any suggestions about possible speakers at the April 16th event, or 
if you have any thoughts about how best to raise funds for psychedelic 
research and the work of MAPS, please get in touch by writing to Rick 
Doblin, MAPS, 1801 Tippah Avenue, Charlotte, NC 28205, or calling at 
(704) 358-9830, FAX 358-1650.  

---------------  Publications, Audiotapes & Videotapes  ----------------

Publications available from MAPS

1. Exploring Ecstasy.  A Description of MDMA Users.  Final Report to the 
National Institute on Drug use.  Marsha Rosenbaum, Principal 
Investigator, Patricia Morgan,Co-Principle Investigator, Jerome Beck, 
Project Director.  253 pages.  Cost - $30.  

2. The MDMA Controversy Context of Use and Social Control, Jerry Beck's 
PhD thesis for a Doctor of Public Health from the U.of Cal, Berkeley.  
271 pages.  Cost - $30.  

3. Hallucinogen-Assisted Psychotherapy:  A Survey of the Swiss 
Association for Psycholytic Therapy, Dr.  Ernst Benz's PhD.  thesis for 
the University of Zurich, 100 pages.  Available only in German $30.  

4. Through the Gateway of the Heart, edited by Sophia Adamson and Ralph 
Metzner and signed by Ralph Metzner, $9.95 plus $1.50 postage.  

5. Proceedings of the MAPS Swiss Psychedelic Research Methodology 
Conference, talks and papers by Albert Hofmann, Lewis Seiden, George 
Ricaurte & others.  150 pages, $25.  

6. PIHKAL by Sasha and Ann Shulgin.  $18.95(+$4.00 p/h), California 
residents add $1.38 tax.  

7. MDMA Psychotherapy in End-Stage Cancer Patients-The Protocol - 49 
pages, $10.  

8. The Good Friday Experiment Follow-Up, the article on psychedelics and 
experimental mysticism by Rick Doblin, published in the August, 1991 
Journal of Transpersonal Psychology, $8.  

9. Against Excess Drug Policy for Results, Mark A. Kleiman - $26.  

10.  Journal of Nervous and Mental Disease paper analyzing self-reports 
of 20 psychiatrists about their own MDMA experiences, OUT Magazine 
article on MDMA, and December 1992 High Times interview with Rick Doblin, 
23 pages, $8.  

11.  Complete set of MAPS Newsletter back issues, 1988-1p., 1989-4p., 
1990-10p., 1991-12p., 1991-4p., 1991-12p., 1992-16p., 1992-24p.- $25.  

Audiotapes and Videotapes Available from MAPS

1. MAPS February, 1990 Benefit Video - 3.5 hour Extended Version, $35.  

2. MAPS February, 1990 Benefit Video - 1.5 hour Artistically Edited 
   Version, $35.

3. Stanford, February, 1991 Conference Video - 2 hour Artistically 
   Edited Version, $35.

4. Prague, June, 1992 Video - 2 hours Rough Unedited Version, Panels #1 & 
   2, $35 .

5. Prague, June, 1992 - 3 hour audiotape of MAPS discussion on working 
   with the terminally ill with psychedelics, Ram Dass, Ken Ring, and
   Richard Yensen, $20.

MAPS                
1801 Tippah Avenue  
Charlotte, NC  28205
phone (704) 358-9830
FAX   (704) 358-1650

-----------------------  Membership Information  ----------------------
                                                                   
MAPS Membership Information                                      
                                                                               
MAPS is a membership-based organization working to assist psychedelic 
researchers around the world design, obtain governmental approval, fund, 
conduct and report on psychedelic research in humans.  Founded in 1986, 
MAPS is an IRS approved 501 (c)(3) non-profit corporation funded by tax 
deductible donations from about two hundred members.  MAPS' founder and 
current president, Rick Doblin, is on leave of absence from the PhD.  
program in Public Policy at Harvard's Kennedy School of Government and 
has previously graduated from Stan and Christina Grof's Holotropic 
Breathwork 3 year training program.  
                                                                      
MAPS has previously funded basic scientific research in both humans and 
animals into the safety of MDMA (methylenedioxymethamphetamine, Ecstasy) 
and has opened a Drug Master File for MDMA at the U.S.  Food and Drug 
Administration.  MAPS is now focused primarily on assisting scientists 
to conduct human studies to generate essential information about the 
risks and psychotherapeutic benefits of MDMA and other psychedelics, 
with the goal of eventually gaining governmental approval for their 
medical uses.  
                                                                           
Albert Einstein wrote that "Imagination is more important than 
knowledge."  If you can even faintly imagine a cultural re-integration 
of the use of psychedelics and the states of mind they engender, please 
consider joining MAPS in supporting the expansion of scientific 
knowledge in this area.  Progress is possible with the support of 
individuals who care enough to take individual and collective action.  
In addition to supporting research, your contributions will return to 
you the following benefits:  
                                                                          
The MAPS Newsletter Each quarterly newsletter will report on MAPS 
research in progress.  In addition to reporting on our own studies, the 
newsletter will focus on psychedelic research both in the US and abroad 
and on conferences, books and articles of interest.  Issues raised in 
letters and calls from members will be addressed, as will political 
developments that effect psychedelic research and usage.  
                                                                             
General Membership:  $30.  (If outside US add $10 postage.)  General 
members will receive the newsletter and the June 1992, Journal of 
Nervous and Mental Disease article on the self-reports of 20 
psychiatrists about their personal use of MDMA, with critique and 
commentary by Dr.  Charles Grob, the OUT Magazine feature story on MDMA, 
and the December 1992 High Times interview with Rick Doblin.  
                                                                              
Supporting Membership:  S100.  (If outside US add $10 postage.)  
Supporting members will receive all the benefits sent to the General 
Members plus the Prague audiotapes of the MAPS discussion on working 
with the terminally ill with psychedelics, featuring Ram Dass, Ken Ring 
and Richard Yensen.  
                                                                               
Patron:  S250 or more.  (If outside US add S10 postage.)  Patrons will 
receive all the benefits sent to Supporting Members plus one item of 
your choice from among the four different videotapes.  Patrons may also 
request research updates at any time on matters of personal interest and 
will receive advance information and discounts to MAPS events.  
                                                                             
"The real difficulty, the difficulty that has baffled the sages of all 
times, is rather this:  how can we make our teaching so potent in the 
emotional life of man, that its influence should withstand the pressure 
of the elemental psychic forces in the individual?"  Albert Einstein 

Membership Form

YES!  I would like to join the Multidisciplinary Association for 
Psychedelic Studies.  

Enclosed is my tax-deductible contribution of:  __ $30 __ $100 __ $250 
or more __ $ other 

If outside the US, add $10 for postage.

NOTE: Your donation will not be spent on animal studies.

Name:
Address:
City:
State:
Zip:
Country:

PATRONS - CHECK THE MEMBERSHIP BENEFIT YOU PREFER:
__ I prefer the Prague 2-hour rough unedited videotape of Panels #1 2.
__ I prefer the MAPS Benefit 3.5 hour Video.
__ I prefer the MAPS Benefit 1.5 hour Video, artistically edited by 
   Sound Photosynthesis.
__ I prefer the Bridge Conference 2 hour Video, artistically edited by 
   Sound Photosynthesis.

MAPS                
1801 Tippah Avenue  
Charlotte, NC  28205
phone (704) 358-9830
FAX   (704) 358-1650
Newsgroups: alt.drugs